Harvard, 10x accuse NanoString of infringing gene sequencing tech

Harvard College and 10x Genomics have sued Nanostring Technologies, alleging that the company’s CosMx imaging platform infringes two patents covering “gene-mapping” technology.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Vizgen accuses Harvard and 10x of patent licence cover-up

4 May 2023 Firm says patents-in-suit were developed using $19 million of public money | Biotech also cites “new evidence” in suit with Harvard and 10x.

Americas

Biotech escalates genetic analysis tech dispute

24 October 2022 The complaint centres on profiling tech used in genetic analysis | Last year, 10x Genomics accused NanoString of infringing multiple patents related to spatial profiling.

Big Pharma

Harvard, 10x say Vizgen infringes genomics patents

5 May 2022 Harvard College and 10x Genomics have sued Vizgen, claiming that the Massachusetts-based biotech rival infringes five patents covering molecular analysis methods.

More on this story

Americas

Vizgen accuses Harvard and 10x of patent licence cover-up

4 May 2023 Firm says patents-in-suit were developed using $19 million of public money | Biotech also cites “new evidence” in suit with Harvard and 10x.

Americas

Biotech escalates genetic analysis tech dispute

24 October 2022 The complaint centres on profiling tech used in genetic analysis | Last year, 10x Genomics accused NanoString of infringing multiple patents related to spatial profiling.

Big Pharma

Harvard, 10x say Vizgen infringes genomics patents

5 May 2022 Harvard College and 10x Genomics have sued Vizgen, claiming that the Massachusetts-based biotech rival infringes five patents covering molecular analysis methods.

More on this story

Americas

Vizgen accuses Harvard and 10x of patent licence cover-up

4 May 2023 Firm says patents-in-suit were developed using $19 million of public money | Biotech also cites “new evidence” in suit with Harvard and 10x.

Americas

Biotech escalates genetic analysis tech dispute

24 October 2022 The complaint centres on profiling tech used in genetic analysis | Last year, 10x Genomics accused NanoString of infringing multiple patents related to spatial profiling.

Big Pharma

Harvard, 10x say Vizgen infringes genomics patents

5 May 2022 Harvard College and 10x Genomics have sued Vizgen, claiming that the Massachusetts-based biotech rival infringes five patents covering molecular analysis methods.

More features

UKIPO rejects Boehringer’s SPC for horse inhaler

Bayer, Orion take on Indian generic over $117bn drug

‘We created law’: G1/24 and the creation of the ‘diamond standard’

BMS unit loses cell therapy patent at European Patent Office

Amgen sues Biocon over blockbuster bone drugs as first biosimilars enter market

Lord Justice Birss to become chancellor of the High Court

Bankruptcy judge approves $305m sale of genetics testing company

Sanofi successfully challenges rare disease patent in Europe

Harvard, 10x accuse NanoString of infringing gene sequencing tech

More on this story

Editor's picks

Editor's picks

More on this story

More on this story

More features